121 related articles for article (PubMed ID: 16216500)
1. Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C.
Lavergne O; Fernandes AC; Bréhu L; Sidhu A; Brézak MC; Prévost G; Ducommun B; Contour-Galcera MO
Bioorg Med Chem Lett; 2006 Jan; 16(1):171-5. PubMed ID: 16216500
[TBL] [Abstract][Full Text] [Related]
2. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
Park H; Bahn YJ; Ryu SE
Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
[TBL] [Abstract][Full Text] [Related]
3. Beta-C-glycosiduronic acids and beta-C-glycosyl compounds: new PTP1B inhibitors.
Lin L; Shen Q; Chen GR; Xie J
Bioorg Med Chem Lett; 2008 Dec; 18(24):6348-51. PubMed ID: 18993066
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of caulibugulones A-E.
Wipf P; Joo B; Nguyen T; Lazo JS
Org Biomol Chem; 2004 Aug; 2(15):2173-4. PubMed ID: 15280951
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.
Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S
Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405
[TBL] [Abstract][Full Text] [Related]
6. Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
Byun JH; Kim H; Kim Y; Mook-Jung I; Kim DJ; Lee WK; Yoo KH
Bioorg Med Chem Lett; 2008 Oct; 18(20):5591-3. PubMed ID: 18793854
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole- and benzoxazole-based inhibitors of Rho kinase.
Sessions EH; Yin Y; Bannister TD; Weiser A; Griffin E; Pocas J; Cameron MD; Ruiz C; Lin L; Schürer SC; Schröter T; LoGrasso P; Feng Y
Bioorg Med Chem Lett; 2008 Dec; 18(24):6390-3. PubMed ID: 18996009
[TBL] [Abstract][Full Text] [Related]
8. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
[TBL] [Abstract][Full Text] [Related]
10. [In vitro inhibitory effect of dibenzoxanthene CY-B12 on proliferation of tumor cell lines and its possible mechanisms].
Pu XX; Jiang GF; Chen Y; Xu ZL; Xian LJ
Ai Zheng; 2005 Dec; 24(12):1442-7. PubMed ID: 16351789
[TBL] [Abstract][Full Text] [Related]
11. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
[TBL] [Abstract][Full Text] [Related]
12. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
[TBL] [Abstract][Full Text] [Related]
13. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.
Hu L; Jiang JD; Qu J; Li Y; Jin J; Li ZR; Boykin DW
Bioorg Med Chem Lett; 2007 Jul; 17(13):3613-7. PubMed ID: 17482458
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of macrocyclic inhibitors of phosphatase cdc25B.
Bäurle S; Blume T; Günther J; Henschel D; Hillig RC; Husemann M; Mengel A; Parchmann C; Schmid E; Skuballa W
Bioorg Med Chem Lett; 2004 Apr; 14(7):1673-7. PubMed ID: 15026048
[TBL] [Abstract][Full Text] [Related]
15. Synthesis by radical cyclization and cytotoxicity of highly potent bioreductive alicyclic ring fused [1,2-a]benzimidazolequinones.
Lynch M; Hehir S; Kavanagh P; Leech D; O'Shaughnessy J; Carty MP; Aldabbagh F
Chemistry; 2007; 13(11):3218-26. PubMed ID: 17200920
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
Kim DK; Lim JH; Lee JA; Dewang PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel anticancer compounds based on a quinoxalinehydrazine pharmacophore.
Deng J; Taheri L; Grande F; Aiello F; Garofalo A; Neamati N
ChemMedChem; 2008 Nov; 3(11):1677-86. PubMed ID: 18985651
[TBL] [Abstract][Full Text] [Related]
18. Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.
Tang J; Hamajima T; Nakano M; Sato H; Dickerson SH; Lackey KE
Bioorg Med Chem Lett; 2008 Aug; 18(16):4610-4. PubMed ID: 18662874
[TBL] [Abstract][Full Text] [Related]
19. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
20. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
